ImageneBio, Inc. (IMA): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$80.16M
Year ended 2023-12-31
2020-12-31: -$38.59M2021-12-31: -$62.01M2022-12-31: -$75.54M2023-12-31: -$80.16M-$80.16M
2020-12-31 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$80.16Mn/m2025-03-06, From 2023-01-01
2022-12-31-$75.54Mn/m2024-03-12, From 2022-01-01
2021-12-31-$62.01Mn/m2023-03-14, From 2021-01-01
2020-12-31-$38.59Mn/a2022-03-17, From 2020-01-01